Patient Testimonial

OPDP wants corrective ads for violative EpiPen TV spot

By

FDA's Office of Prescription Drug Promotion issued a warning letter to Mylan and Pfizer for an EpiPen TV ad that the agency said hyped the effectiveness of the drug.

Email Newsletters